Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton & Afisi S Ismaila. (2023) Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 719-731.
Read now
Read now
Stephen A. Brunton & D. Kyle Hogarth. (2023) Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns. Postgraduate Medicine 0:0, pages 1-19.
Read now
Read now
Taraneh Bahremand, Mahyar Etminan, Nardin Roshan-Moniri, Mary A De Vera, Hamid Tavakoli & Mohsen Sadatsafavi. (2021) Are COPD Prescription Patterns Aligned with Guidelines? Evidence from a Canadian Population-Based Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 751-759.
Read now
Read now
Jørgen Vestbo, Claus F Vogelmeier, Mark Small, James Siddall, Robert Fogel & Konstantinos Kostikas. (2019) Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 853-861.
Read now
Read now
Diego Sangiorgi, Valentina Perrone, Stefano Buda & Luca Degli Esposti. (2017) Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study. Cogent Medicine 4:1.
Read now
Read now
Kieran J Rothnie, Hana Müllerová, Sara L Thomas, Joht S Chandan, Liam Smeeth, John R Hurst, Kourtney Davis & Jennifer K Quint. (2016) Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. Clinical Epidemiology 8, pages 771-782.
Read now
Read now
Evie Merinopoulou, Mireia Raluy-Callado, Sreeram Ramagopalan, Sharon MacLachlan & Javaria Mona Khalid. (2016) COPD exacerbations by disease severity in England. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 697-709.
Read now
Read now
Articles from other publishers (24)
Habibollah Azarbakhsh, Mahin Abdipour & Leila Moftakhar. (2023) Years of life lost due to chronic obstructive pulmonary disease in Khuzestan province during 2011–2019: A population-based study. Lung India 40:1, pages 37.
Crossref
Crossref
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Núria Saigí-Morgui, Annalisa Rubino, Sami Z. Daoud, Alejhandra Lei, Susana Perez-Gutthann, Tania Schink, Nina Sahlertz Kristiansen, Jesper Hallas, Anton Pottegård & Cristina Rebordosa. (2022) Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical Drug Investigation 42:4, pages 319-331.
Crossref
Crossref
Holly Mitzel, Dakota Brown, Morgan Thomas, Byrne Curl, Mackenzie Wild, Andrea Kelsch, Judge Muskrat, Abulquasem Hossain, Ken Ryan, Olawale Babalola, Madison Burgard & Masfique Mehedi. (2022) Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD. Medicina 58:2, pages 254.
Crossref
Crossref
Knut Sindre Mølmen, Daniel Hammarström, Gunnar Slettaløkken Falch, Morten Grundtvig, Lise Koll, Marita Hanestadhaugen, Yusuf Khan, Rafi Ahmad, Bente Malerbakken, Tore Jørgen Rødølen, Roger Lien, Bent R. Rønnestad, Truls Raastad & Stian Ellefsen. (2021) Chronic obstructive pulmonary disease does not impair responses to resistance training. Journal of Translational Medicine 19:1.
Crossref
Crossref
Hannele Siltanen, Tiina Aine, Heini Huhtala, Marja Kaunonen & Eija Paavilainen. (2021) The information needs of people with COPD—The holistic approach with special reference to gender and time since diagnosis. Nursing Open 8:5, pages 2498-2508.
Crossref
Crossref
Dave Singh, James F. Donohue, Isabelle H. Boucot, Neil C. Barnes, Chris Compton & Fernando J. Martinez. (2021)
Future concepts in bronchodilation for COPD: dual-
versus
monotherapy
. European Respiratory Review 30:160, pages 210023.
Crossref
Crossref
Mathew Cherian, Dennis Jensen, Wan C. Tan, Sara Mursleen, Emma C. Goodall, Gilbert A. Nadeau, Amnah M. Awan, Darcy D. Marciniuk, Brandie L. Walker, Shawn D. Aaron, Denis E. O'Donnell, Kenneth R. Chapman, François Maltais, Paul Hernandez, Don D. Sin, Andrea Benedetti & Jean Bourbeau. (2021) Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study. ERJ Open Research 7:2, pages 00960-2020.
Crossref
Crossref
Georgina Nakafero, Matthew J Grainge, Puja R Myles, Christian D Mallen, Weiya Zhang, Michael Doherty, Jonathan S Nguyen-Van-Tam & Abhishek Abhishek. (2020) Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs. Rheumatology 59:12, pages 3666-3675.
Crossref
Crossref
Daiana Stolz, Konstantinos Kostikas, Emil Loefroth, Robert Fogel, Florian S. Gutzwiller, Valentino Conti, Hui Cao & Andreas Clemens. (2019) Differences in COPD Exacerbation Risk Between Women and Men. Chest 156:4, pages 674-684.
Crossref
Crossref
Samuel P. Trethewey, Ross G. Edgar, Julien Morlet, Rahul Mukherjee & Alice M. Turner. (2019) Late presentation of acute hypercapnic respiratory failure carries a high mortality risk in COPD patients treated with ward-based NIV. Respiratory Medicine 151, pages 128-132.
Crossref
Crossref
Madonna Ferrone, Marcello G. Masciantonio, Natalie Malus, Larry Stitt, Tim O’Callahan, Zofe Roberts, Laura Johnson, Jim Samson, Lisa Durocher, Mark Ferrari, Margo Reilly, Kelly Griffiths, Christopher J. Licskai, Andrew Atkins, Bill Baker, Sara Dalo, Jean Piccinato, Denise Waddick & Brice Wong. (2019) The impact of integrated disease management in high-risk COPD patients in primary care. npj Primary Care Respiratory Medicine 29:1.
Crossref
Crossref
N. Pires, P. Pinto, N. Marçal, A.J. Ferreira, C. Rodrigues & C. Bárbara. (2019) Pharmacological treatment of COPD – New evidence. Pulmonology 25:2, pages 90-96.
Crossref
Crossref
Cristina Rebordosa, Estel Plana, Jaume Aguado, Steven Thomas, Esther García-Gil, Susana Perez‐Gutthann & Jordi Castellsague. (2018) GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiology and Drug Safety 28:2, pages 126-133.
Crossref
Crossref
Miriam Barrecheguren, Cruz González & Marc Miravitlles. (2018) What have we learned from observational studies and clinical trials of mild to moderate COPD?. Respiratory Research 19:1.
Crossref
Crossref
Lianne Parkin, Wayne Khuu, Matthew B. Stanbrook, Mina Tadrous, Diana Martins & Tara Gomes. (2018) Trends in the utilisation of COPD therapeutic regimens before and after the introduction of LAMA/LABA combination products: A population-based study. Respiratory Medicine 143, pages 1-7.
Crossref
Crossref
András Bikov, Alpár Horváth, Gábor Tomisa, Liza Bártfai & Zoltán Bártfai. (2018) Changes in the Burden of Comorbidities in Patients with COPD and Asthma–COPD Overlap According to the GOLD 2017 Recommendations. Lung 196:5, pages 591-599.
Crossref
Crossref
Lianne Parkin, David Barson, Jiaxu Zeng, Simon Horsburgh, Katrina Sharples & Jack Dummer. (2018) Patterns of use of long-acting bronchodilators in patients with COPD: A nationwide follow-up study of new users in New Zealand. Respirology 23:6, pages 583-592.
Crossref
Crossref
J. Sehl, J. O’Doherty, R. O’Connor, B. O’Sullivan & A. O’Regan. (2017) Adherence to COPD management guidelines in general practice? A review of the literature. Irish Journal of Medical Science (1971 -) 187:2, pages 403-407.
Crossref
Crossref
. (2017) Single inhaler triple therapy for COPD. Drug and Therapeutics Bulletin 55:12, pages 138-141.
Crossref
Crossref
Han Ni, Aung Htet & Soe Moe. (2017) Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2017:6.
Crossref
Crossref
Rachel E Jordan, Peymané Adab, Alice Sitch, Alexandra Enocson, Deirdre Blissett, Sue Jowett, Jen Marsh, Richard D Riley, Martin R Miller, Brendan G Cooper, Alice M Turner, Kate Jolly, Jon G Ayres, Shamil Haroon, Robert Stockley, Sheila Greenfield, Stanley Siebert, Amanda J Daley, K K Cheng & David Fitzmaurice. (2016) Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial. The Lancet Respiratory Medicine 4:9, pages 720-730.
Crossref
Crossref
Miriam Barrecheguren, Mónica Monteagudo, Jaume Ferrer, Eulalia Borrell, Carl Llor, Cristina Esquinas & Marc Miravitlles. (2016) Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study. Respiratory Medicine 111, pages 47-53.
Crossref
Crossref
Rolandas Zablockis & Edvardas Danila. (2015) Lėtinės obstrukcinės plaučių ligos ambulatorinio gydymo kompensuojamaisiais vaistais tvarkos laikymosi vertinimas. Sveikatos mokslai 25:5, pages 131-135.
Crossref
Crossref
Han Ni, Aung Htet & Soe Moe. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.